Skip to content
Tenfell
Awarded contract
Published 18 Nov 2021

PF-07321332 Supply Agreement for Pandemic Purposes

Department of Health and Social Care · London

Key facts

Contract value
£2
Awarded
17 Oct 2021
Contract starts
17 Oct 2021
Contract ends
31 Dec 2022
Procedure
Negotiated procedure without prior publication (above threshold)
Buyer type
Central government

Awarded to

SupplierValue
Pfizer Ltd£1

Description

Vaccines have been shown to be highly effective in the fight against COVID-19, to date. However, there is a cohort of individuals who either cannot take the vaccine or for whom it is ineffective. There is therefore an urgent need to find an effective alternative. So far there are no primary care antiviral drugs that can be easily dispensed specifically to treat SARS-CoV-2 and prevent its transmission in the community. This agreement is for the procurement of 250,000 units of PF-07321332/ritonavir . It is one of the first oral and direct-acting antiviral drugs globally and is part of the UK's multi-layered approach to COVID-19.

Categories (CPV)

Similar open tenders

About Department of Health and Social Care

Their tenders, awards, contracts coming up for renewal, decision makers and committee papers.

View buyer profile

Their other open tenders

Published by the buyer on Contracts Finder archive (Open Contracting) (Open Government Licence v3.0). Always read the original notice before responding.